T1	Participants 352 384	osteosarcoma and Ewing's sarcoma
T2	Participants 401 473	Rhabdomyosarcoma Study (IRS) IV patients with group III rhabdomyosarcoma
T3	Participants 599 742	444 group III patients who received induction therapy, had response assessed at week 8 by anatomic imaging, and continued with protocol therapy
